A patient with elevated Lp(a): What is current clinical practice to manage this condition?
May 27, 2016 - Innsbruck, Germany - Prof. Klaus G. Parhofer, MD - University of Munich, Germany - FRIDAY, MAY 27, 2016, lunch symposium at Lp(a) symposium prior to EAS
Elevated Lp(a) levels as an independent and additive CV risk factor 0:41
When to treat a patient with elevated Lp(a)? 1:20
Currently available drugs to lower Lp(a) levels 2:07
Effect of lipoprotein apheresis on Lp(a) levels 5:32
Does lowering Lp(a) levels improve clinical outcomes? 6:21
How are patients currently treated - treatment algorithm 9:10
Faculty & Disclosures
Prof. Klaus G. Parhofer, MD – is Professor of Endocrinology and Metabolism at the University of Munich in Germany.
Funding
The PACE foundation received funding for this session via an unrestricted educational grant from Amgen
View the slides of this presentation
